Semi-Annual Consolidated Statement Of Cash Flows

Pharma Foods International Co., Ltd. - Filing #7273863

Concept 2024-08-01 to
2025-01-31
As at
2025-01-31
As at
2024-07-31
As at
2024-01-31
2023-08-01 to
2024-01-31
As at
2023-07-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
645,000,000 JPY
1,542,000,000 JPY
Depreciation
336,000,000 JPY
254,000,000 JPY
Amortization of goodwill
33,000,000 JPY
63,000,000 JPY
Increase (decrease) in allowance for doubtful accounts
-2,000,000 JPY
0 JPY
Interest and dividend income
-17,000,000 JPY
-14,000,000 JPY
Interest expenses
41,000,000 JPY
27,000,000 JPY
Increase (decrease) in retirement benefit liability
-16,000,000 JPY
-10,000,000 JPY
Foreign exchange losses (gains)
3,000,000 JPY
-3,000,000 JPY
Share of loss (profit) of entities accounted for using equity method
67,000,000 JPY
0 JPY
Increase (decrease) in provision for bonuses
8,000,000 JPY
8,000,000 JPY
Decrease (increase) in trade receivables
205,000,000 JPY
602,000,000 JPY
Decrease (increase) in inventories
-170,000,000 JPY
194,000,000 JPY
Increase (decrease) in trade payables
-93,000,000 JPY
84,000,000 JPY
Other, net
-367,000,000 JPY
-320,000,000 JPY
Subtotal
1,159,000,000 JPY
3,050,000,000 JPY
Interest and dividends received
17,000,000 JPY
14,000,000 JPY
Interest paid
-41,000,000 JPY
-27,000,000 JPY
Income taxes paid
-1,313,000,000 JPY
-283,000,000 JPY
Net cash provided by (used in) operating activities
19,000,000 JPY
2,835,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-425,000,000 JPY
-376,000,000 JPY
Purchase of investment securities
-64,000,000 JPY
-200,000,000 JPY
Other, net
27,000,000 JPY
-8,000,000 JPY
Net cash provided by (used in) investing activities
-464,000,000 JPY
-602,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
300,000,000 JPY
Repayments of long-term borrowings
-446,000,000 JPY
-490,000,000 JPY
Purchase of treasury shares
JPY
-999,000,000 JPY
Dividends paid
-421,000,000 JPY
-346,000,000 JPY
Net cash provided by (used in) financing activities
-4,110,000,000 JPY
-1,542,000,000 JPY
Other, net
-4,000,000 JPY
-5,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-3,000,000 JPY
3,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-4,559,000,000 JPY
694,000,000 JPY
Cash and cash equivalents
11,006,000,000 JPY
15,566,000,000 JPY
17,001,000,000 JPY
16,306,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.